Paula Gergen
Lawyers
Filters
Oruka Therapeutics $200 million at-the-market offering
We advised Oruka on the offering
Oruka Therapeutics $180 million private placement
The PIPE included common stock and pre-funded warrants
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
MARA Holdings $950 million convertible notes offering
The 0% convertible senior notes are due 2032
xAI $3 billion senior secured notes offering
The senior secured notes are due 2030
Omada Health $172.6 million IPO
The shares are listed on the Nasdaq Global Select Market
indie Semiconductor $218.5 million convertible senior notes offering
The 3.5% convertible senior notes are due 2029
Fastly $150 million convertible senior notes offering
The 7.75% convertible notes are due 2028
Guidewire Software $690 million convertible senior notes offering
The 1.25% convertible notes are due 2029
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030